HURA
TuHURA Biosciences Inc
NASDAQ: HURA · HEALTHCARE · BIOTECHNOLOGY
$2.10
-1.41% today
Updated 2026-04-29
Market cap
$141.14M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.63
Dividend yield
—
52W range
$0 – $4
Volume
1.1M
TuHURA Biosciences Inc (HURA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-3.85M | $-5.15M | $-8.02M | $-9.85M | $-6.33M | $-7.93M | $-18.86M | $-6.56M | $-7.51M | $-7.18M | $-14.73M |
| Capital expenditures | $3.85M | $4.00 | $1.00 | $9.85M | $5.00 | $0.00 | $8000.00 | $3280.00 | $232000.00 | $79224.00 | $57906.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | — | — | — | $654529.00 | $218275.00 | $478890.00 | $1.96M |
| Free cash flow | $-7.71M | $-5.15M | $-8.02M | $-19.70M | $-6.33M | $-7.93M | $-18.87M | $-6.57M | $-7.74M | $-7.26M | $-14.79M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | $6267.00 | $8356.00 | $8356.00 | $8356.00 | $8356.00 | $8000.00 | $8000.00 | $8000.00 | — | — | $0.00 |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — |